The therapeutic role of 5-HT1A and 5-HT2A receptors in depression.
2004 · PubMed · 492 citations
P
Pau Celada
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
130
Papers
6.3K
Citations
39
h-index
69
i10-index
Pau Celada is an academic researcher from Instituto de Salud Carlos III. The author has contributed to research in topics: Neurotransmitter Receptor Influence on Behavior & Neuroscience and Neuropharmacology Research & Treatment of Major Depression. The author has an h-index of 39, co-authored 111 publications.
ORCID: 0000-0002-3893-9000Papers by this author
worksCan we increase speed and efficacy of antidepressant treatments? Part I: General aspects and monoamine-based strategies
2017 · European Neuropsychopharmacology · 90 citations
https://doi.org/10.1016/j.euroneuro.2017.10.032
Preclinical and clinical characterization of the selective 5‐HT<sub>1A</sub>receptor antagonist DU‐125530 for antidepressant treatment
2011 · British Journal of Pharmacology · 46 citations
https://doi.org/10.1111/j.1476-5381.2011.01770.x
Relationship Between Blood Serotonergic Variables, Melancholic Traits, and Response to Antidepressant Treatments
1998 · Journal of Clinical Psychopharmacology · 38 citations
https://doi.org/10.1097/00004714-199806000-00007
Effect of Deep Brain Stimulation of the ventromedial prefrontal cortex on the noradrenergic system in rats
2017 · Brain stimulation · 32 citations
https://doi.org/10.1016/j.brs.2017.10.003
Modulation of thalamo-cortical activity by the NMDA receptor antagonists ketamine and phencyclidine in the awake freely-moving rat
2019 · Neuropharmacology · 30 citations
https://doi.org/10.1016/j.neuropharm.2019.107745
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat